Drug Shortage Report for ARNUITY ELLIPTA
| Report ID | 212815 |
| Drug Identification Number | 02446561 |
| Brand name | ARNUITY ELLIPTA |
| Common or Proper name | fluticasone furoate dry powder for oral inhalation |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUTICASONE FUROATE |
| Strength(s) | 100MCG |
| Dosage form(s) | POWDER |
| Route of administration | ORAL INHALATION ORAL INHALATION |
| Packaging size | 1x30 |
| ATC code | R03BA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-07 |
| Estimated end date | 2024-01-31 |
| Actual end date | 2024-01-24 |
| Shortage status | Resolved |
| Updated date | 2024-01-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-01-26 | French | Compare |
| v5 | 2024-01-26 | English | Compare |
| v4 | 2024-01-03 | French | Compare |
| v3 | 2024-01-03 | English | Compare |
| v2 | 2023-12-08 | French | Compare |
| v1 | 2023-12-08 | English | Compare |
Showing 1 to 6 of 6